Point-prevalence Surveys of Antimicrobial Consumption and Resistance at a Paediatric and an Adult Tertiary Referral Hospital in Yangon, Myanmar
Overview
Authors
Affiliations
Background: Antimicrobial resistance is increasingly prevalent worldwide. The inappropriate use of antimicrobials, including in the hospital setting, is considered a major driver of antimicrobial resistance.
Aim: To inform improvements in antimicrobial stewardship, we undertook point prevalence surveys of antimicrobial prescribing at Yangon Children's Hospital and Yangon General Hospital in Yangon, Myanmar.
Methods: We conducted our surveys using the Global Point-Prevalence Survey of Antimicrobial Consumption and Resistance (Global-PPS) method. All inpatients who were prescribed an antimicrobial on the day of the survey were included in the analysis.
Findings: We evaluated a total of 1,980 patients admitted to two hospitals during December 2019. Of these, 1,255 (63.4%) patients were prescribed a total of 2,108 antimicrobials. Among antimicrobials prescribed, 722 (34.3%) were third-generation cephalosporins, the most commonly prescribed antimicrobial class. A total of 940 (44.6%) antimicrobials were prescribed for community-acquired infection, and 724 (34.3%) for surgical prophylaxis. Of 2,108 antimicrobials, 317 (15.0%) were prescribed for gastrointestinal tract prophylaxis, 305 (14.5%) for skin, soft tissue, bone and joint prophylaxis, and 303 (14.4%) for pneumonia treatment. A stop or review date was documented for 350 (16.6%) antimicrobial prescriptions, 673 (31.9%) antimicrobial prescriptions were guideline compliant, and 1,335 (63.3%) antimicrobials were administered via the parenteral route. Of 1,083 antimicrobials prescribed for a therapeutic use, 221 (20.4%) were targeted therapy.
Conclusion: Our findings underscore the need to update and expand evidence-based guidelines for antimicrobial use, promote the benefits of targeted antimicrobial therapy, and support the implementation of hospital-based antimicrobial stewardship programmes at the hospitals surveyed.
Sheikh S, Saleem Z, Afzal S, Qamar M, Raza A, Haider Naqvi S Front Pediatr. 2025; 12:1469766.
PMID: 39867700 PMC: 11759272. DOI: 10.3389/fped.2024.1469766.
Ul Mustafa Z, Salman M, Khan A, Harun S, Meyer J, Godman B Infect Drug Resist. 2024; 17:5411-5428.
PMID: 39664724 PMC: 11631696. DOI: 10.2147/IDR.S491454.
Hosseininasab A, Barshan F, Farsiu N, Nakhaie M, Soltani J, Versporten A BMC Infect Dis. 2024; 24(1):1300.
PMID: 39543480 PMC: 11566745. DOI: 10.1186/s12879-024-10159-9.
Tapha O, Degbey C, Yacouba A, Mahouna Tchioundjro E, Nadakou N, Alkassoum Salifou I JAC Antimicrob Resist. 2024; 6(5):dlae175.
PMID: 39478985 PMC: 11523492. DOI: 10.1093/jacamr/dlae175.
Chanapal A, Cheng H, Lambert H, Cong W JAC Antimicrob Resist. 2024; 6(3):dlae093.
PMID: 38863558 PMC: 11166085. DOI: 10.1093/jacamr/dlae093.